Low-Power Holmium Laser Therapy for Urethral Strictures at Ninh Thuan Province General Hospital, Vietnam

Read full text
Authors: Thach Le-Huy, Thắng Lê Quốc, Phuong Dang Quoc, Thien Dong Xuan, Truyen Bao Dai, Trang Tu Xuan, Linh Truong Thi My, Francesco Inchingolo, Kieu CD Nguyen, Luigì Santacroce, Ciro Gargiulo Isacco
Cited by: 0

Abstract

INTRODUCTION: Urethral stricture is a common urological disease characterized by a narrowing of the urethra leading to functional changes that reduce or completely block urine flow from the kidney to the bladder. This condition significantly affects the patient's quality of life and can lead to serious complications, such as urethral dilatation and hydronephrosis, which may result in irreversible kidney failure if left untreated. METHODS: This was an observational cross-sectional study conducted on 35 patients, treated for urethral stricture at the Department of Uro-nephrology Surgery, Ninh Thuan Province General Hospital, from January to October 2023. RESULTS: All enrolled patients underwent urethral stricture endoscopic incision using holmium laser, and were followed up at 1 and 3 months postoperatively. The difference in the degree of hydronephrosis on CT scans before and after surgery at 3 months was statistically significant (p < 0.01). DISCUSSION: To report the safety and efficacy outcomes of holmium laser urethrotomy for the treatment of urethral stricture, patients underwent internal urethrotomy with holmium laser energy, with an average age of 47.7 ± 15.8 years (range: 15-72 years). Thirty patients (85.7%) underwent urological surgery, 3 (8.6%) underwent obstetric and gynecological surgery, and 2 (5.7%) had unknown etiologic causes. CONCLUSION: The use of the holmium laser for the management of urethral strictures has been found to be safe and effective, ensuring shorter operating times, a lower recurrence rate, and fewer serious postoperative complications.

Fields of Study & Subjects

Urological Disorders and Treatments Ureteral procedures and complications Urinary Bladder and Prostate Research

Publication details

Journal / source
Endocrine Metabolic & Immune Disorders - Drug Targets
Volume
26
Pages
e18715303389695–e18715303389695
Publication date
27 January 2026
Language
EN